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ROUTINE OPT-OUT HIV TESTING IN JAILS: FINDINGS FROM TWO
PROSPECTIVE CONTROLLED TRIALS. Ravi Kavasery, Duncan Maru, Joshua
Cornman-Homonoff, Laurie Sylla, David Smith, and Frederick Altice. Section of
Infectious Diseases, Department of Internal Medicine, Yale University, School of
Medicine, New Haven, CT.
Background: Tens of millions of Americans enter jails annually. The Centers for
Disease Control and Prevention now recommends routine HIV testing in prisons and
jails. The logistics for performing routine HIV testing within jails, however, remains
controversial.
Specific Aims:
1) To simulate and explore the feasibility of future implementation of a routine optout HIV testing protocol using rapid testing methods in the often-chaotic jail
setting.
2) To evaluate the optimal time to perform routine HIV testing among inmates who
are competent to consent to testing, in a manner that not only maximizes public
health but also attends to the safety and health status of individual inmates.
Methods: Two prospective, controlled trials of routine opt-out HIV testing were
conducted among 323 newly incarcerated female inmates in Connecticut‟s only women‟s
jail (during August and September 2007) and 298 newly incarcerated male inmates in an
urban men‟s jail in New Haven, Connecticut (during March and April 2008). Sequential
entrants at both facilities were assigned to be offered routine opt-out HIV testing at one
of three points after incarceration: immediate (same day), early (next day), or delayed (7
days). The primary outcome was the proportion of individuals in each group consenting
to testing.
Results: In the women‟s trial, routine opt-out HIV testing was significantly highest
(73%) among the early testing group compared to 55% for immediate and 50% for 7 days
post-entry groups. Other factors significantly (p=0.01) associated with being HIV tested
were younger age and low likelihood of early release from jail based on bond value or
type of charge for which women were arrested. In the men‟s trial routine opt-out HIV
testing was significantly higher for the early (53%: AOR=2.6; 95% CI=1.5 to 4.7) and
immediate (45%: AOR=2.3; 95% CI=1.3 to 4.0) testing groups compared to the delayed
(33%) testing group. The immediate and early testing groups, however, did not
significantly differ (p=0.67). In multivariate analyses, factors significantly associated
with routine opt-out HIV testing were assignment to the „early‟ testing group (p=0.0003)
and low (bond $5,000, immigration or federal charges or pre-sentencing >30 days)
likelihood of early release (p=0.04). Two male subjects received preliminary positive
results and one of them was subsequently confirmed HIV seropositive.
Conclusions: In both correctional facilities, routine opt-out HIV testing in a jail setting
was feasible, with highest rates of testing if performed within 24 hours of incarceration.
Lower testing rates were seen with immediate testing, where there is a high prevalence of

inability or unwillingness to test, and with delayed testing, where attrition from jail
increases with each passing day.
Trial Registration: ClinicalTrials.gov NCT00624247
http://clinicaltrials.gov/ct2/show/NCT00624247

The findings from these trials have been previously presented at the 46th Annual Meeting
of the Infectious Diseases Society of America in Washington, DC in October 2008. In
addition, findings from both trials were previously published as companion pieces in
PLoS One in November 2009.
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1
Introduction
Over 2.3 million people, or one in every 100 American adults, are incarcerated and
their initial interface with the correctional system is usually via jail.[1-2] The prevalence
of HIV infection in the United States is also several-fold greater in correctional settings
than in the general population.[3] One-quarter of HIV-infected individuals in the United
States pass through a correctional facility every year and it is believed that anywhere
from one third to one half of these persons are unaware of their HIV status.[4-6] Jails
and prisons thus serve as important sites for HIV testing and treatment.[5, 7-9]
The Centers for Disease Control and Prevention (CDC) recently recommended
implementing routine opt-out HIV testing in all healthcare settings, including jails,
acknowledging that HIV testing guided by risk factor assessment alone misses many of
those who are HIV-infected.[10] As recently as 2007, however, HIV testing practices
continued to be largely based on the pretesting probability that a patient had identifiable
risk factors.[11] Yet, approximately 50% of individuals who enter correctional settings
do not know their HIV status and many with HIV infection do not have traditional riskbased behaviors for HIV.[9, 12] Therefore, enhanced HIV testing strategies in
correctional settings remain a high priority.
The revised CDC recommendations call for routine testing in all clinical settings,
the central goal being to maximize the number of persons who are aware of their HIV
infection and receive care and prevention services. According to the CDC guidelines for
routine testing, “HIV-negative results may be conveyed without direct personal contact
between the patient and the health-care provider.” Only HIV positive results should be
communicated confidentially through personal contact by a clinician, nurse, mid-level
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practitioner, counselor, or other skilled staff. Furthermore, the guidelines state that
prevention counseling should not be required as a part of HIV screening programs in
health-care settings. [10]
Understanding the issues related to implementing routine opt-out HIV testing in
jails presents both a challenge and an opportunity in correctional settings to expand
access to HIV services to correctional inmates. [10, 13-14] Historically, performing HIV
testing in jails has been difficult. Jails interact with a larger number of individuals at risk
for HIV infection than do prisons; however, jails also pose unique logistical and healthrelated constraints for implementing widespread HIV screening programs. Jails differ
from prisons in several important ways that impact HIV testing strategies: 1) jail
populations have short periods of incarceration and high rates of turnover with many-fold
greater admissions and discharges; 2) jails house individuals with higher rates of acute
intoxication from psychoactive drugs, uncontrolled mental illness, and suicidal
behavior;[15] and 3) the individuals who enter jails have higher recent risk behaviors for
HIV than those in prisons.[16-17] Given these considerations, jails have been less wellequipped to implement screening, prevention, and treatment programs to address patients
with or at risk for HIV/AIDS.
Recent advances in testing diagnostics, however, have created promising
opportunities for screening in jail settings. The development of the OraQuick rapid HIV1 antibody test, for example, allows for the prompt delivery of preliminary positive and
definitively negative results within twenty minutes.[18] Recent cost-benefit analyses also
support expanded HIV screening in all settings, especially in sites where the prevalence
of HIV exceeds 1%;[19-20] the prevalence of HIV in jails in the Northeast exceeds that
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amount several-fold and would likely yield the highest number of unidentified HIVinfected individuals.
Current HIV testing practices in U.S. jails are highly variable. Nearly one-fifth of
jails report no official HIV testing protocol, [21] and as few as 21.6% of jail inmates
were HIV tested after admission.[22] Surveys conducted by the CDC and the National
Institute of Justice, report that only 4% of jails provide HIV testing upon inmate request
and only 2% offer routine HIV testing on admission; none of those surveyed mandated
HIV testing of incoming inmates.[23]
Experience with rapid HIV testing in jail settings is limited.[24-25] To date, only
two such studies have been published. One study, conducted among female inmates
during intake at the Cook County Jail, consisted of approaching detainees in the corner of
a large room, in open view of security officers and fellow inmates, and offering them
rapid HIV testing. Among this group, 30% were found to be ineligible; however,
ineligibility was not systematically defined. Additionally, and perhaps as a result of
requiring inmates to consent in a public setting, less than half of those approached were
willing to accept testing.[24] A more recent study was conducted at the Rhode Island
Department of Corrections Jail, a facility where routine HIV testing has been in place for
over 15 years.[25] Although 95% of participants accepted rapid HIV testing, 87%
reported they had been previously HIV tested at this facility during a prior incarceration.
Moreover, the time after incarceration was not provided, suggesting that inmates may
have been longer term inmates and we were not told how many were ineligible for HIV
testing at all. Given these circumstances, concerns remain whether the results of the
Rhode Island study can be generalized to other correctional settings. In addition to these
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studies, the CDC has funded four Jail Demonstration Projects in Florida, Louisiana, New
York and Wisconsin, encompassing more than 23 jails in those states. The program,
which offers voluntary rapid HIV testing based on referral, has conducted over 33,000
tests and found that 1.1% of individuals were positive, 70% of whom were previously
unknown cases of HIV.[26]
None of the aforementioned studies adequately addresses the screening of inmates
for psychological distress, intoxication, and withdrawal prior to conducting widespread
HIV testing.

A major challenge to implementing a routine HIV testing protocol in jails

is determining the optimal time to test, taking into account an inmate‟s ability to consent
to testing and his or her level of psychological distress. Because the incarcerated
experience high rates of suicidal behavior, mental illness, acute intoxication, and
withdrawal, they might not be competent to consent to HIV testing or to receive a
positive HIV test result, even though these same individuals might also be at highest risk
for infection.[21, 25] Therefore, when choosing the appropriate time to screen inmates
for HIV, testing must be performed in a manner that not only maximizes public health,
but also attends to the safety and health status of individual inmates. It is well
documented that inmates are more likely to experience mental distress and present at a
higher risk for committing suicide within the first 48 hours of incarceration.[15, 27-29]
A ten-year study of deaths in the Chicago Cook County jail found that suicides were the
third leading cause of death among inmates, following heart and cerebrovascular
disease.[30] In addition, studies of jail populations at time of admission show that acute
symptoms of serious mental illnesses requiring treatment are present in about 6% of
males and 15% of females at booking.[31-32]
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Prisoners might be too distressed at their time of admission to consider the
consequences of being HIV tested. In particular, distressed individuals might not be
prepared to receive a positive HIV test result. Furthermore, recently incarcerated
prisoners might be intoxicated or experiencing symptoms of withdrawal, thereby
preventing them from providing informed consent. The challenge with postponing
testing is that many individuals experience very short stays in jail, with about 1/3 leaving
within 48 hours, followed by further attrition daily for the first week. Therefore, every
day that testing is delayed a greater number of inmates will leave jail without being
tested. Although several authors have acknowledged the importance of screening jail
inmates for mental status and suicide risk before conducting widespread HIV testing, no
literature exists evaluating the tradeoffs between early versus late testing with regard to
individual health needs and public health benefit.
The CDC has identified several major issues that must be addressed when developing
model routine HIV testing strategies in jails. These include: 1) choosing the timing of
testing after jail entry; 2) marketing and advertising of services; 3) manner in which
testing is presented to inmates; 4) testing protocols; 5) methods of informing those tested
of their results; 6) confidentiality of results; 7) HIV counseling associated with testing;
and 8) administrative and implementation issues.[33]

6
Statement of Purpose, Specific Hypotheses, Specific Aims
Statement of Purpose
To evaluate the optimal time to conduct routine opt-out HIV testing of newly
incarcerated male and female jail inmates in a manner that maximized the number of
individuals capable of consenting and willing to be tested.

Specific Hypotheses
1. A higher proportion of inmates approached for testing the night of intake will be
deemed incompetent to consent to testing (using the standardized MacArthur
Competence Assessment Tool) compared to those inmates approached in the days
after intake.
2. A higher proportion of inmates approached for testing the night of intake will
present at a higher risk for suicidal ideation and psychological distress (according
to the nursing staff‟s mental health assessments and the standardized K6
psychological distress scale) compared to those inmates approached in the days
after intake.
3. A higher proportion of inmates approached for testing the night of intake will not
receive HIV testing (because they are either deemed incompetent or choose not to
provide consent for testing) compared to inmates approached on subsequent days.
4. A significant portion of individuals assigned to being approached for HIV testing
on Day 7 will leave the facility prior to Day 7 and will miss the opportunity to be
tested.
5. Correctional medical and custodial staff will express resistance to implementing
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widespread routine HIV testing in jail settings.

Specific Aims
1. To simulate and explore the feasibility of future implementation of a routine optout HIV testing protocol using rapid testing methods in the often-chaotic jail
setting;
2. To determine the ability of subjects to pass a competency assessment in order to
consent to routine HIV testing at varying times after entry into jail
3. To examine the acceptability among jail inmates of a routine HIV testing protocol
using rapid HIV testing methods;
4. To evaluate the optimal time to perform routine HIV testing among inmates who
are competent to consent to testing, in a manner that not only maximizes public
health but also attends to the safety and health status of individual inmates.
5. To assess the attitudes toward future widespread implementation of a routine
rapid HIV testing protocol by correctional, medical, and custodial staff
6. To assess the feasibility of implementing routine HIV testing in jails at different
time points during and after entry processing from a systems operations
perspective
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Methods
Ethics Statement
These trials were approved by the Institutional Review Board at Yale University and
by the Connecticut Department of Correction Research Committee.

Design Overview
These two prospective, controlled trials were conducted among female and male
inmates in two Connecticut jails from 2007 to 2008. Over a 5-week period starting
August 22, 2007, all 323 consecutive, newly incarcerated female inmates at York
Correctional Institution were offered routine opt-out HIV testing after being sequentially
assigned to one of three study arms upon admission to the facility: 1) „immediate‟
(during a mandatory initial medical screen the night of admission); 2) „early‟ (during a
required physical exam the following evening); or 3) „delayed‟ (7 days after arrival to the
facility). The same study design was used for all 298 consecutive, newly incarcerated
male inmates at New Haven Community Correctional Center from March 25, 2008 to
April 16, 2008.
Decisions about timing for routine opt-out HIV testing were based upon previous
surveys of correctional and medical professionals as well as from experts in the field of
HIV testing in correctional settings. These three time points were chosen to coincide
with other routine healthcare activities at the jail in order to simulate the future
implementation of a routine opt-out HIV testing protocol.
When designing the study protocol, review of the scientific literature suggested that
not only do men and women have different attitudes toward HIV testing in jail or in
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general, but they are also likely to present with different rates of mental illness and
substance withdrawal that could potentially affect the primary outcome. Additionally,
the policymaking process is largely made independently for male and female jails.
Therefore, the men‟s and women‟s trials were intended as separate studies with separate
analyses.

Although the primary outcome was the same for both trials, the primary

outcome was assessed independently for the male and female jails.

Setting and Participants
The women‟s trial was conducted at York Correctional Institution in Niantic,
Connecticut, the state‟s sole correctional facility for women. Intake involves both
sentenced and pre-trial detainees. The average daily census is 1641 inmates. Testing for
pregnancy, opioids, tuberculosis and acute medical conditions is routinely conducted.
Inmates maintained on or experiencing opioid withdrawal symptoms are provided a
methadone taper. The evening following admission, a routine physical examination,
including Papanicolaou smear and phlebotomy, occurs in all new inmates remaining
within the facility. [12]
The men‟s trial was conducted at the New Haven Community Correctional Center
(NHCCC) in New Haven, Connecticut, an urban men‟s jail that houses primarily
unsentenced detainees as well as those serving sentences ≤1 year. The facility‟s average
daily census is 919 individuals.
At both the men‟s and women‟s study sites, similar to other jails, a brief, standardized
medical and psychiatric assessment is routinely conducted on all inmates, including
medical, sexual, and drug-use histories immediately upon arrival. Voluntary HIV testing
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is available by medical referral or by self-request and often involves being placed on a
waiting list. Current policy in Connecticut requires that in the absence of an emergent
clinical indication, inmates must be beyond the three month “window period” from their
last HIV risk behavior to receive an HIV antibody test. Newly confirmed HIV positive
test results are reported to the Connecticut Department of Public Health as part of the
state‟s mandatory reporting system.
As part of this study, all newly incarcerated inmates were sequentially approached for
competency and HIV testing and sequentially assigned to one of the three study groups.
Eligibility to be HIV tested required demonstration of competency by: 1) clinicianconfirmed ability to demonstrate knowledge of the risks, benefits, and consequences of
HIV testing in accordance with the MacArthur Competence Assessment Tool for Clinical
Research [MacCAT-CR][34]; and 2) no self-reported suicidal ideation or evidence of
mental instability.

Intervention
For each testing group, the inmate was approached with the following scripted
statement: “As part of your regular medical care, HIV testing can now be done using an
oral swab that you swipe across your gums. You can receive your results after 20
minutes. Would you like to be tested at this time?” If the inmate responded affirmatively,
he or she was instructed to self-administer the oral HIV test by the clinical staff in the
„immediate‟ and „early‟ test groups as part of routine clinical activities in order to
simulate how routine opt-out HIV testing would be performed if not embedded within a
complicated research study. On day 7, research personnel oversaw the verbal consent
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and self-administration procedures using the same process. All subjects were instructed
that HIV results require minimal waiting. Anyone not wanting to know HIV test results
was not swabbed. If the inmate agreed to be swabbed and tested, he or she subsequently
met with a research assistant who discussed two written informed consents – one for
study participation and one for HIV testing (legislatively mandated). Inmates who
initially agreed to be swabbed but refused to provide both written consents did not have
their HIV swabs tested and these specimens were immediately discarded. These
individuals, along with anyone not wanting testing were informed voluntary HIV testing
was available through self-referral from an HIV counselor. Those who self-identified as
being HIV-infected were not swabbed.

Outcomes and Follow-up
Oral swab testing was conducted onsite using the OraQuick ADVANCE  rapid HIV1 antibody test [sensitivity: 99.3% (98.4-99.7), specificity: 99.8% (99.6-99.9)].[18, 35]
The primary outcome, assessed independently for the male and female jails, was the
proportion of individuals in each assigned group that provided verbal consent to be
swabbed for HIV testing.
Individuals were not swabbed for HIV testing if they were physically not available
(e.g., released from jail, at court, attorney visits, too ill), were deemed medically
incompetent to provide consent, or opted out of HIV testing. The primary outcome,
using a public health perspective, was analyzed using an intention-to-treat (ITT) approach
and included all inmates admitted to the jail during the study period, as assigned. The
intention-to-treat analysis assessed whether an inmate was swabbed, regardless of
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whether he or she subsequently agreed to take part in the research protocol. Any subject
for whom swab results were missing was deemed “failure to swab” in the analysis;
however, there were no missing data in the final database. A secondary outcome, to
assess individual acceptability of HIV testing, was the proportion of inmates who agreed
to HIV testing among those still under correctional supervision at the time that testing
was offered.
Pre-test counseling was not provided. Subjects who received a preliminary positive
test result were immediately referred for phlebotomy for confirmatory testing with
Western blot. Certified HIV counselors provided preliminary-positive post-test
counseling and confirmatory results; study staff delivered negative results.
As an additional secondary analysis, inmates deemed competent to receive testing
who provided written consent were asked about previous HIV testing experiences,
attitudes toward HIV testing in jail settings and were also administered a series of
standardized instruments: Clinical Opiate Withdrawal Scale [COWS], [36] Clinical
Institute Withdrawal Assessment of Alcohol Scale [CIWA-Ar], [37] and the Kessler 6Item Psychological Distress Scale (K6).[38]
To determine if the three testing groups in each trial differed with regard to social and
demographic characteristics, the Connecticut Department of Correction (CTDOC)
database was queried to abstract demographic characteristics [age and race (defined by
CTDOC)], type of charge and bond value. No unique identifiers were provided. Low
likelihood of early release was defined as a bond value $5,000, sentencing > 30 days,
immigration or federal charges, or no bond allowed. High HIV-risk charges were
considered to be any charges directly related to prostitution or drugs.
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Statistical Analysis
The primary outcome was the proportion of individuals in each testing group who
were orally swabbed and provided verbal consent to receive rapid HIV testing. Using
two-sided Chi-Square tests for assessing three pair-wise differences between the different
study arms and applying Bonferroni‟s correction (i.e., alpha=0.0166 for each
comparison), we sought to collect 97 patients in each arm to achieve 80% power to detect
a 22% difference between arms given a baseline uptake of 60%. Comparisons of
demographic, correctional and refusal characteristics were conducted using two-sided
Chi-Square tests (alpha=0.05).
After calculating the bivariate associations with the primary outcome, a multiple
logistic regression model was developed to predict the likelihood of being swabbed using
the available subject characteristic variables. The Akaike information criterion (AIC)
was used to assess model fit; lower AIC values indicate a better balance of parsimony
and explanation of variance. In conjunction with AIC, a p-value of 0.30 was used to
enter and leave the model. The optimal model was chosen as the convergence of the
forward and backward models, with consideration of parsimony and plausibility. The
two-sided Wald‟s test (alpha=0.05) was used to assess significance of each of the
variables. All statistical analyses were conducted using SAS, version 9.1.3 (SAS
Institute).
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Results
Women’s Trial
The baseline characteristics of the study population for the women‟s trial are shown
in Table 1. During the study period, 323 newly incarcerated women were sequentially
assigned to the following testing groups: „immediate‟ (N=108, the night of admission),
„early‟ (N=108, the following evening), and „delayed‟ (N=107, 7 days later). The three
study groups did not differ significantly with respect to any of the social and
demographic characteristics assessed.
The disposition of individuals approached for routine opt-out HIV testing in this trial
is illustrated in Figure 1. Overall, 192 (59%) of 323 inmates assigned to testing groups
provided verbal consent to be swabbed for HIV testing. For the primary outcome, 79
(73%) of those offered „early‟ testing, received an HIV test, compared to 59 (55%)
assigned to the „immediate‟ and 54 (50%) assigned to the „delayed‟ testing groups
(Figure 2). The early testing group was significantly more likely to be tested than both
the immediate group (OR=2.3; 95% CI=1.3-4.0; p=0.007) and the delayed group
(OR=2.7; 95% CI=1.5-4.7; p=0.0007). The proportion swabbed in the immediate and
delayed testing groups, however, did not differ (OR=1.2; 95% CI=0.7-2.0; p=0.54). To
assess the individual acceptability of HIV testing, 268 subjects were physically present
within the jail at the three time points when routine opt-out testing was made available
(see Figure 2). Acceptability was highest for the early testing group (N=79/91, 87%),
compared to 76% (N=54/71) in the delayed and 56% (N=59/106) in the immediate
testing group (p<0.05 for all comparisons).
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Stratified by testing group, the reasons that inmates were not swabbed are depicted in
Table 2. In the „immediate‟ group (N=108), 12 (11%) were medically incompetent to
consent, compared with only 4 (4%) in each of the „early‟ (N=108) and „delayed‟
(N=107) testing groups. This difference was significant (OR=3.2; 95% CI=1.3-8.2;
p=0.009; not depicted in Table 2). In the „delayed‟ testing group, 36 (34%) did not
appear for testing compared with 4 (4%) in the „immediate‟ and 17 (16%) in the „early‟
testing groups (OR comparing delayed to other: 4.7; 95% CI: 2.6-8.6; p=0.000001; not
depicted in Table 2). The most common reasons for failing to be available for testing
included being released from the facility (either paid bond or released from court),
appearing in court that day, or rarely, logistical barriers within the jail setting that
prevented movement within the facility. Among the 54 competent subjects who declined
testing, 27 (54%) stated they did not perceive themselves at risk, 10 (19%) declared they
were already HIV-infected (all were confirmed by medical record review), and 8 (15%)
stated they were too tired, fearful of testing, or experiencing withdrawal.
Figure 3 demonstrates the attrition-decay curve from this jail expressed over time.
The median duration of incarceration was 28 days; among the 323 subjects approached,
90 (28%) were no longer incarcerated after 7 days, 118 (37%) after 14 days, and 247
(76%) at 90 days after admission. The highest attrition rate was within the first 24 hours
with 11% (n=34) leaving the facility during this time. These individuals, compared to
those who were released at later times, trended toward having less opiate-positive urine
test results (11% vs. 26%, p=0.06) and were less likely to be jailed for sex- or drugrelated charges (11% vs. 26%, p=0.06). They were also significantly less likely to have
been previously incarcerated (43% vs. 66%, p=0.009). Bivariate and multivariate
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analyses were conducted to determine predictors associated with being swabbed for HIV
testing (Table 3). In the bivariate analysis, assignment to the „early‟ testing group,
younger age, low-likelihood of release, high HIV-risk charges, and being Hispanic were
associated with being swabbed for HIV testing. In the multivariate analysis, assignment
to the „early‟ testing group (p<0.001), younger age (p=0.01), and low likelihood of
release (p=0.01) remained significantly associated with being swabbed for HIV testing.
Of the 192 individuals who were swabbed, 151 (79%) provided written consent to
complete the entire study. Two additional participants failed to pass the MacArthur
Competence Assessment Tool, leaving 149 (79%) individuals eligible to be HIV tested.
Of these, 147 (99%) were HIV-negative and two had a preliminary-positive test result;
both results were false-positive after obtaining confirmatory Western Blot testing. Thus,
none of the 149 people tested were diagnosed as being HIV-infected. Two negative test
results (one from the „immediate‟ and one from the „early‟ testing groups) were not
delivered due to the inmate having left the facility.
Among the 149 subjects HIV-tested subjects that underwent standardized screening,
11 (7%) exhibited moderate or severe opioid withdrawal symptoms: three (7%) from
„immediate‟, eight (15%) from „early‟ group, and none from the „delayed‟ testing group.
Ten (7%) individuals were deemed to have increased risk for alcohol withdrawal
symptoms: three (7%) from „immediate‟, seven (13%) from „early‟, and none from the
„delayed‟ testing group. In addition, 50 (34%) of the 149 tested subjects had evidence of
serious mental illness using the K6 psychological distress scale score: 11 (24%) from
„immediate‟, 22 (42%) from „early‟, and 17 (33%) from the „delayed‟ testing group.
Nearly all (89%) of these 149 subjects self-reported having been HIV tested previously,
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but only 32% reported testing within the previous year. The most recent HIV testing had
occurred previously at a community organization (n=32, 21%), hospital (n=30, 20%), or
correctional facility (n=29, 19%).

Men’s Trial
The baseline characteristics of the study population from the men‟s trial appear in
Table 4. The 298 newly incarcerated men were sequentially assigned to the following
testing groups: „immediate‟ (N=103, the night of admission), „early‟ (N=98, the
following evening), and „delayed‟ (N=97, 7 days later). The three study groups did not
differ significantly with respect to any of the social and demographic characteristics
assessed.
The disposition of individuals approached for routine opt-out HIV testing in this trial
is illustrated in Figure 4. Overall, 130 (44%) of 298 inmates assigned to testing groups
provided verbal consent to be swabbed for routine opt-out HIV testing. Among those
assigned to early testing, 52 (53%) accepted HIV testing versus 46 (45%) in the
immediate and 32 (33%) for 7 days post-entry groups (Figure 5). Compared to the
delayed testing group, the early (OR=2.6; 95% CI=1.5 to 4.7; p =0.001) and immediate
(OR=2.3; 95% CI=1.3 to 4.0; p = 0.01) testing groups were significantly more likely to
be swabbed for HIV testing. The immediate and early testing groups did not differ with
regard to the primary outcome (p=0.67).
There were differences between these two groups, however, in rates of acceptance
among those actually physically available and medically competent to be approached for
testing. Of the 226 subjects that were physically present in the jail at each of the three
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time points, acceptability was highest for the early testing group (N=52/74, 70%),
compared to 45% (N=46/103) and 65% (N=32/49) in the immediate and delayed testing
groups, respectively (see Figure 5).
Stratified by testing group assignment, the reasons that inmates were not swabbed are
depicted in Figure 6. In the immediate group, 5 (10% of those not swabbed in that group)
were medically incompetent or did not have the capacity to consent, compared with none
in the „early‟ and in the „delayed‟ testing groups. In the „delayed‟ testing group, 48 (75%
of those not tested) were no longer available for testing compared with none in the
„immediate‟ and 24 (57% of those not tested) in the „early‟ groups. Among the 77
competent subjects who declined testing, 18 (23%) stated they were not interested in
general, 15 (19%) did not perceive themselves to be at risk, 12 (16%) self-reported they
were already HIV-infected (confirmed by medical record review), and 11 (14%) stated
they were recently tested.
Figure 7 demonstrates the time to release from the facility. The median duration of
incarceration at the facility was 34 days. Among the 298 subjects approached, 51 (17%)
were released within the first 24 hours following admission, 81 (29%) were no longer
incarcerated after 7 days, 107 (36%) after 14 days, and 142 (48%) were already released
at 30 days. Individuals released within the first 24 hours following admission were less
likely to have been incarcerated previously: 33 (65%) versus 211 (85%) (p=0.0005); the
two groups did not vary on any other characteristics.
Bivariate and multivariate analyses were conducted to determine predictors
associated with being swabbed for routine opt-out HIV testing (Table 5). In the bivariate
analysis, assignment to the „immediate‟ or „early‟ testing groups was associated with
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being swabbed for HIV testing. In the multivariate analysis, however, only assignment to
the „early‟ testing group (p=0.0003) and low likelihood of release (p=0.04) were
significantly associated with being swabbed for HIV testing.
Of the 144 individuals swabbed, 130 (90%) provided written consent to complete the
entire study. Of these, 128 (98.5%) were HIV-negative and 2 (1.5%) had a preliminary
positive test result; one was a false-positive and the other was confirmed using Western
Blot testing. The one confirmed negative test occurred in the “immediate testing group”.
Both individuals who tested preliminary positive were incarcerated at seven days and
both received their confirmatory test results. Based on the 12 confirmed individuals
known to be HIV-infected and the one newly diagnosed subject in this study, the
minimum HIV prevalence for this facility is 13/298 (4.4%).
Among the 130 HIV-tested subjects who underwent standardized screening, 15 (12%)
exhibited moderate or severe opioid withdrawal symptoms: 6 (13%) from „immediate‟, 4
(8%) from „early‟ group, and 5 (16%) from the „delayed‟ testing group. Only 3 (2%)
individuals were deemed to have increased risk for alcohol withdrawal symptoms: 1 (2%)
from „immediate‟, 2 (4%) from „early‟, and none from the „delayed‟ testing group. In
addition, 17 (13%) of the 130 tested subjects had evidence of serious mental illness using
the K6 psychological distress scale score: 5 (11%) from „immediate‟, 9 (17%) from
„early‟, and 3 (9%) from the „delayed‟ testing group.
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Discussion
To our knowledge, these represent the first prospective, controlled trials of routine
opt-out HIV testing among inmates in any jail setting, a population that typically
experiences high rates of psychological distress, rapid turnover, and both acute
intoxication and withdrawal upon admission. Previously, voluntary testing had been
shown to have limited uptake rates; one multicenter study tested only 6% of ~550,000 jail
detainees using voluntary testing methods. [39] One observational study conducted
recently in a Rhode Island jail demonstrated markedly higher rates of acceptability of
testing compared to that found in our study. [25] The likely explanation for this
difference is that mandatory HIV testing of prisoners has been in place in that state for
nearly 20 years. As such, nearly all (88%) subjects had previously been tested within that
setting and the authors themselves suggest that HIV testing was no longer considered as
an emotional or “charged” issue. It can therefore be expected that acceptance of routine
opt-out HIV testing will increase with time as the stigma and unfamiliarity with testing
decreases among correctional staff and inmates. Additionally, a 4-site, CDC funded study
demonstrated that rapid, voluntary HIV testing is feasible and identified many new
people living with HIV. However, inmates often were tested days to weeks after
incarceration, thereby potentially missing a large number of high risk individuals who
were released prior to testing.[39] New initiatives examining HIV testing strategies in
jails are now underway.[26]
Our results have two major public health implications. First, routine opt-out HIV
testing in jails is feasible, whether provided immediately upon intake or a day or week
later. The operational details of our program should provide guidance to jails
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implementing routine opt-out HIV testing. The characteristics of the available jail
population vary over time such that delays in testing result both in reduced likelihood of
testing but also missing the important opportunity to HIV test those who have never
interfaced with the correctional environment.
Second, our results suggest that testing within the first 24 hours after entry increases
the number of individuals who receive HIV testing. This is likely due to optimizing the
balance between allowing time for psychological and medical stabilization of the
individual and expeditiously providing testing prior to individuals leaving the facility.
The magnitude of these effects are of significant public health importance, in that 73% of
those women approached the evening after admission were swabbed for HIV testing,
compared to 55% and 50% of those approached immediately or seven days post-entry,
respectively. This benefit was seen despite the fact that 11% of female inmates at this
facility were released within the first 24 hours.
Likewise, the primary outcome from the men‟s trial demonstrated that offering
routine opt-out HIV testing to male inmates in this urban jail within the first 24 hours of
admission resulted in the highest likelihood of being HIV tested (53%). This suggests
that routine opt-out HIV testing in jails should be offered as early in the intake process as
possible. To balance the competing factors of risk of release with inmate willingness to
accept testing, it may be beneficial to offer routine opt-out HIV testing at intake and
again at a subsequent medical appointment within 24 hours if the inmate is not tested the
night of intake.
The proportion of individuals choosing to opt out of testing the night of admission
was high in both the women‟s and men‟s studies (32% and 50%, respectively). Inmates
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in both trials were also considerably more willing to accept testing when offered the day
after entry. Of the 268 women physically present in the facility at the time they were
offered, 87% of those approached the evening after admission verbally consented to
testing, compared to 56% and 75% of those in the immediate and delayed testing groups,
respectively. Similarly, in the men‟s trial, among inmates physically present in the jail at
the time of testing, 55% of those approached in the immediate group opted out, versus
30% in the early group. The attrition rate due to inmates quickly bonding out, however,
resulted in the equalization of swabbing rates between these two groups. In contrast to the
women‟s jail, the trial among male inmates was conducted at an urban facility with more
daily admissions and a higher rate of release within the first twenty-four hours. These
dynamics of increased attrition in the men‟s jail may account for the lost benefit of
waiting until the day following entry to maximize uptake of HIV testing.
Testing inmates on the day of incarceration may be less optimal because these
individuals are distraught from being arrested and tired from remaining in court or in a
holding cell all day. The substantial increase in willingness to test 24 hours after
admission may reflect acceptance of being incarcerated, in addition to having had a night
of sleep. Though unclear from these data, acceptability among women decreased after
remaining in the jail after 7 days, perhaps explained by the impact of peer pressure and/or
recognition of potential stigma from HIV testing. Despite acceptability being slightly
lower among those women approached for testing one week post-entry, a higher
proportion consented than found in voluntary HIV testing programs in other correctional
settings.[39-40]
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In the women‟s trial, the most common reasons for not being swabbed for HIV
testing included early release from the facility (presumably due to posting bond), failing
to demonstrate medical competency to consent to testing, and choosing not to be HIV
tested. On multivariate analysis, additional factors significantly associated with receiving
HIV testing were younger age (conferring a 7% decrease in the likelihood of testing for
every ten years of increasing age) and having bond set above $5,000 (conferring nearly a
2-fold reduced likelihood of being released). Ability or willingness to test was
particularly important for testing in the „immediate‟ group. Although almost a third of
individuals assigned to „immediate‟ testing refused testing (Figure 2), only 7% of those
approached one day later chose to opt-out.

Those assigned to the „immediate‟ testing

group were also 3-times more likely than either of the other groups to be medically or
psychologically unable to consent to testing. One potential explanation for the higher rate
of testing in the „early‟ testing group, particularly compared to the immediate group, is
that women may have gotten some rest, been initiated on medication-assisted protocols to
treat opioid or alcohol withdrawal, or had become resigned to being in jail.
It was clear that the high-risk women approached for testing in this trial had not been
adequately reached with HIV testing services. While 89% of those who consented to
study participation reported being previously tested for HIV, only 30% had received an
HIV test within the last year, per CDC recommendations for high-risk individuals.
A major strength of the present study design was that it enabled us to accurately
assess realistic acceptance for HIV testing in an ethical manner. Socially marginalized
individuals, such as prisoners, may be leery about participating in research in coercive
places like jails. [2, 41] We overcame this obstacle by asking jail-based clinicians to ask
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individuals to provide verbal consent to be HIV tested before referring them to research
personnel to obtain written consent for study participation. Thus, this trial simulated
what routine opt-out HIV testing within a clinical encounter in jail might look like and
avoids biasing participant response during the encounter. Indeed, approximately 22% of
those female subjects who agreed to be swabbed for rapid HIV testing as part of routine
intake procedures later refused to provide consent for study participation. In most cases,
this was because of subjects‟ suspicion of being involved in research or because of the
time involved in completing several interview instruments at a time when they were tired
or did not feel well. The primary outcome of being swabbed for an HIV test, therefore,
served as a better marker in this trial for acceptance of HIV testing than completion of the
informed consent aspect of the study and thereby receiving an HIV test result.
In addition, a key factor contributing to the higher rate of routine opt-out HIV testing
within the first 24 hours of admission was that the testing procedures were linked to a
routine clinical activity (intake or physical exam) with clinical personnel. This policy, of
linking routine opt-out HIV testing with routine clinical activities, makes logistical sense
and should be considered when implementing testing in the future. It also helps to
demonstrate to inmates that HIV testing is simply a component of comprehensive
primary healthcare. Future observational and controlled studies should assess which staff
members should perform testing and delivery of both positive and negative HIV test
results during the chaotic post-entry period. Our study did not assess this fully; we
utilized jail staff for intake, testing, and follow-up of positive HIV test results, while all
our own research staff provided negative results.
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Although both trials successfully demonstrated the feasibility of routine opt-out HIV
testing in a jail, challenges remain to be addressed before routine opt-out HIV testing is
implemented more widely in other jail settings. Daunting challenges remain to implement
routine opt-out HIV testing upon intake at some of the largest and busiest jails. Several
hundred people may be processed daily, with intake procedures taking place 24 hours a
day.
One of the unresolved issues for routine opt-out HIV testing in jails is ensuring
delivery of confirmatory HIV test results for those who test preliminarily-positive. In the
women‟s trial, only two (0.6%) of the 323 women approached for testing received a
preliminary-positive test result that required a confirmatory blood draw, the results of
which often require up to a week to receive. Similarly, in the men‟s trial, only one
individual was released prior to receiving his negative test result, and both individuals
who tested preliminarily positive were incarcerated at 7 days to receive their final test
results. Although individuals in both trials were still incarcerated in the facility and
therefore able to receive their confirmatory blood draw results a week later, there will be
cases of release prior to receipt of results. Indeed, over one-quarter of the inmates in the
women‟s trial were released within seven days of entry. Delivery of test results,
particularly for individuals who have blood drawn for confirmatory testing, will prove
difficult among this transient population. If routine opt-out HIV testing is to be broadly
implemented in our nation‟s jails, however, delivery of test results will remain an
important issue and requires further resolution. While we await more rapid, confirmatory
testing technology, Western Blot testing remains the accepted standard.

Logistical

issues of providing results in the jail will therefore be incumbent on correctional
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authorities to resolve, yet public health infrastructure must be maintained to address case
finding and delivery of results to those who leave before HIV testing results are available.
As is typical of many urban jails in the United States, the study site for the men‟s trial
houses a population with rapid turnover. Nearly a fifth of new admissions were released
by the next day, with 29% no longer remaining in the facility within a week. This raises
significant questions about the current policy in Connecticut of requiring HIV testing
only on those inmates with at least 90 days since their last HIV risk behavior. Continuing
such a policy would result in nearly three quarters of jail detainees being ineligible for
HIV testing because they would already be released.
An additional important finding was in both the men‟s and women‟s trials, those
having a low likelihood for release were more likely to consent to testing, regardless of
group assignment. This suggests that, in jail systems with high volumes that preclude
testing of all inmates at entry, triage systems could be useful in focusing initial testing
efforts on those inmates for whom early release is more likely. While the men‟s study
did diagnose one new individual with HIV, it likely missed many other high risk
individuals who left the facility before being offered testing as part of their assigned
testing group.
There are several important limitations of the present trials. Owing to logistical
difficulties, we could not undertake a true randomized trial. This makes it possible that
confounders, such as cohort effects from particular peer leaders‟ influence on testing
uptake, biased our results (internal validity). Our large sample size and final effect size
suggests, however, that the differences detected here were real. Additionally, since our
trials were restricted to a single female and male correctional facility, the findings may
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not be generalizable to other jail settings (external validity).Not all jails provide routine
clinical assessments the day following admission, and others may not provide any routine
healthcare services at all.[42] Furthermore, large, metropolitan correctional facilities
experiencing many-fold higher daily admissions may face additional logistical challenges
in implementing testing as part of intake procedures.
In conclusion, our study confirms that routine opt-out HIV testing in a jail setting is
feasible and that early testing will likely result in the largest number of individuals being
tested. This approach balances the medical and psychiatric instability seen among those
immediately upon incarceration with the high attrition rate demonstrated by those tested 7
days later. Early testing also results in testing a larger proportion of those who have
never been within the correctional system before and have previously received an HIV
test. Such programs, if implemented properly, will result in identifying individuals with
HIV who do not know they are infected and increase their likelihood of reducing their
HIV risk behaviors and increasing their access to HIV treatment and prevention services.
Notwithstanding the merits of answering the logistical question of when to HIV test,
many other questions remain, including how to avoid repeat testing, costs associated with
increased HIV testing and barriers associated with written informed consent.
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Figure 3: [Women’s Trial] Time to Release Following Incarceration
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Figure 4. [Men’s Trial] Disposition of Inmates Approached for HIV Testing
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Figure 5. [Men’s Trial] Rapid HIV Testing Swab Results by Assigned Testing
Group
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Figure 6. [Men’s Trial] Reasons Inmates were not Swabbed for HIV Testing
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Figure 7. [Men’s Trial] Time to Release Following Incarceration
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Table 1: [Women’s Trial] Baseline Characteristics of the Study Population (n=323)
Characteristics
Age (mean years; SD)
Length of Current Incarceration
(median days; IQR)
Race

Subcategory

Hispanic
Black
White/Other
Education
High School Graduate
Not a High School Graduate
Likelihood of Early Release*
High
Low
Type of Charge
Drug- or Prostitution-Related
Not Drug- or Prostitution-Related
Previous Incarcerations
Never Incarcerated
Incarcerated Previously
Mean Number of Previous Incarcerations (N; SD)
Medical Insurance
Yes
No
Urine Toxicology
Negative for Opiates
Positive for Opiates
* High: any charges directly related to prostitution or drugs.
Low: bond value  $5000, bond sentencing > 30 days, immigration or federal
charges, or
no bond

Value (%)
33.6 (9.8)
28 (7-94)
53 (16)
104 (32)
166 (51)
201 (62%)
122 (38%)
115 (36)
208 (64)
81 (25)
242 (75)
117 (36)
206 (64)
1.9 (2.4)
120 (37)
203 (63)
242 (75)
81 (25)
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Table 2. [Women’s Trial] Reasons Inmates were not Swabbed for HIV Testing
Reason

Immediate Group

Early Group

Delayed Group

(49 not swabbed of 108)

(29 not swabbed of 108)

(53 not swabbed of 107)

4 (8)

17 (59)

36 (68)

Refused/Declined Swab or Study Participation, n (%)

33 (67)

8 (27)

13 (24)

Medically Incompetent/Failed MacArthur, n (%)

12 (25)

4 (14)

4 (8)

Bonded/Released/At Court, n (%)
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Table 3. [Women’s Trial] Bivariable and Multivariable Predictors of Receipt of
Swab
Uptake
Rates, n (%)

Bivariable
OR (95% CI)

Assigned day 0*

59 (55)

1.2 (0.7 to 2)

Assigned day 1*

79 (73)

Assigned day 7*

54 (50)

Age (yrs) at Entry**
Low Likelihood of
Release
High Likelihood of
Release
High HIV-Risk
Offense
Low HIV-Risk
Offense

2.7 (1.5 to
4.7)
--Referrent--

Bivariable
p-value

Multivariable
OR (95% CI)

Multivariable
p-value

0.54

1.2 (0.7 to
2.1)

0.51

0.0007

2.7 (1.5 to 5)

0.0009

--

--Referrent--

--

--

0.7 (0.6 to
0.9)

0.01

0.7 (0.6 to
0.9)

0.01

133 (64)

1.7 (1.1 to
2.7)

0.03

1.9 (1.1 to
3.1)

0.01

59 (51)

--Referrent--

--

--Referrent--

--

1.7 (1 to 3)

0.04

1.7 (1 to 3)

0.07

--Referrent--

--

--Referrent--

--

0.10

0.7 (0.4 to
1.2)

0.17

0.01

2 (1 to 4.1)

0.07

--

--Referrent--

--

56 (69)
136 (56)

0.7 (0.4 to
1.1)
2.4 (1.2 to
4.7)
--Referrent--

Black

55 (53)

Hispanic

40 (75)

White/Other

97 (58)

Previous
Incarceration

125 (61)

1.2 (0.7 to
1.8)

0.55

-Out of
Model-

--

No Previous
Incarceration

67 (57)

--Referrent--

--

-Out of
Model-

--

Urine Opiate(+)

51 (63)

1.2 (0.7 to 2)

0.46

Urine Opiate(-)

141(58)

--Referrent--

--

118 (59)

0.92 (0.6 to
1.5)

0.73

74 (61)

--Referrent--

--

66 (55)

0.7 (0.5 to
1.2)

0.21

126 (62)

--Referrent--

--

High School
Graduate
Not High School
Graduate
Has Medical
Insurance
No Medical
Insurance

-Out of
Model-Out of
Model-Out of
Model-Out of
Model-Out of
Model-Out of
Model-

*OR Comparing day 1 or day 7, respectively to day 0.
**The calculated OR represents the added likelihood conferred by every 10 years of age

---

---

---
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Table 4: [Men’s Trial] Baseline Characteristics of the Study Population (n=298)
Characteristics
Age (mean years; SD)
Ethnicity

High School Graduate
Length of Current Incarceration
(median days; IQR)
High Likelihood of Early
Release*
Drug- or Prostitution-Related
Offense

Subcategory
Hispanic
Black
White/Other
Yes
No

Value (%)
35 (11)
56 (19)
104 (35)
138 (46)
193 (65)
105 (35)
28 (4-36)

Yes

122 (41)

No
Yes

176 (59)
46 (15)

No
252 (85)
Yes
244 (82)
No
54 (18)
Has Medical Insurance
Yes
276 (93)
No
22 (7)
* High: any charges directly related to prostitution or drugs.
Low: bond value  $5000, bond sentencing > 30 days, immigration or federal charges, or
no bond
Previous History of Incarceration
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Table 5. [Men’s Trial] Bivariable and Multivariable Predictors of Receipt of Swab
Uptake
Rates, n (%)

0.0013

52 (43)

0.7 (0.5 to
1.1)

92 (52)

0.10

0.1 (0.1 to
0.7)

0.04

--Referrent--

--

--Referrent--

--

88 (46)

0.74 (0.5 to
1.2)

0.20

0.8 (0.5 to
1.2)

0.21

56 (53)

--Referrent--

--

--Referrent--

--

131 (47)

1.6 (0.7 to
3.9)

0.30

2 (0.8 to 5.1)

0.15

13 (59)

--Referrent--

--

--Referrent--

--

--

0.9 (0.72 to
1.12)

0.32

-Out of
Model-

--

18 (39)

--Referrent--

--

0.7 (0.4 to
1.3)

0.18

56 (57)

Assigned day 7*

33 (34)

Age (years) at
Entry**
Low HIV-Risk
Offense
High HIV-Risk
Offense

Multivariable
p-value

0.0003

Assigned day 1*

Has Medical
Insurance
No Medical
Insurance

Multivariable
OR (95% CI)
2.4 (1.4 to
4.3)
3.0 (1.7 to
5.6)
--Referrent--

55 (53)

High School
Graduate
Not High School
Graduate

Bivariable
p-value

2.3 (1.26 to
4)
2.6 (1.5 to
4.7)
--Referrent--

Assigned day 0*

Low Likelihood of
Release
High Likelihood of
Release

Bivariable
OR (95% CI)

126 (50)

0.01

--

-Out of
Model-Out of
Model-Out of
Model-Out of
Model-Out of
Model-

0.00

--

---

White/Other

49 (47)

--Referrent--

--

Black

29 (52)

1 (0.6 to 1.5)

0.73

Hispanic

66 (48)

1.2 (0.7 to
2.2)

0.58

No Previous
Incarceration

23 (43)

--Referrent--

--

-Out of
Model-

--

Previous
Incarceration

121 (50)

1.4 (0.8 to
2.5)

0.35

-Out of
Model-

--

*OR Comparing day 1 or day 7, respectively to day 0.
**The calculated OR represents the added likelihood conferred by every 10 years of age

----

